PROLONG PHARMACEUTICALS
Prolong Pharmaceuticals, Inc. develops and markets biopharmaceutical products. Its products include PEG-uricase for the treatment of hyperuricemia; PEG-arginase for the treatment of melanoma and hepatocellular carcinoma; PEG-protein for the treatment of hypovolemic shock; PEG-peptide antibiotic to treat staphylococcus infections; PEG-streptokinase for myocardial infarcts; anti-cancer agents; and Erythropoietin, a biopharmaceutical that provides a solution for anemia. The company also offers custom manufacturing services; and licenses its products to pharmaceutical companies. Prolong Pharmaceuticals, Inc. was founded in 2002 and is based in New Jersey.
PROLONG PHARMACEUTICALS
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2005-01-01
Address:
South Plainfield, New Jersey, United States
Country:
United States
Website Url:
http://www.prolongpharma.com
Total Employee:
51+
Status:
Active
Contact:
908-444-4660
Email Addresses:
[email protected]
Total Funding:
30 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins Mobile Non Scaleable Content
Current Employees Featured
Founder
Official Site Inspections
http://www.prolongpharma.com Semrush global rank: 9.21 M Semrush visits lastest month: 194
- Host name: 198.202.211.1
- IP address: 198.202.211.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
